Related Experiment Video
Updated: Apr 17, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
Clinical controversies in lipid management
1First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece - ktziomalos@yahoo.com.
Statins are crucial for managing dyslipidemia, with benefits outweighing small risks like type 2 diabetes mellitus. Combining statins with ezetimibe or fenofibrate can further optimize cardiovascular risk reduction.
Area of Science:
- Cardiology
- Endocrinology
- Pharmacology
Background:
- Dyslipidemia management relies heavily on statins, yet controversies persist.
- Understanding these controversies is key to optimizing cardiovascular disease (CVD) prevention.
Purpose of the Study:
- To review current evidence on key controversies in lipid management.
- To provide guidance on optimizing dyslipidemia treatment strategies.
Main Methods:
- Review of existing evidence, including randomized controlled trials, mechanistic, genetic, and epidemiological studies.
- Analysis of current lipid-lowering agent efficacy and safety profiles.
Main Results:
- Statin use slightly increases type 2 diabetes mellitus (T2DM) risk, but benefits for CVD prevention are greater.
- Ezetimibe addition is recommended for patients not reaching low-density lipoprotein cholesterol (LDL-C) targets on maximally tolerated statins.
- Fenofibrate addition may reduce cardiovascular risk in patients with elevated triglycerides despite statin therapy.
Conclusions:
- Statin-associated T2DM risk should not deter treatment initiation.
- Combination therapy (statin-ezetimibe or statin-fenofibrate) is valuable for specific patient groups.
- Further research will refine dyslipidemia management for reduced cardiovascular morbidity.
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipids: Dietary Sources and Requirements
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Angina IV: Management

